Brief: Oncternal TherapeuticsOn Jan 22 Entered Into Amendment No. 4 To Amended & Restated License Agreement Between Co,Regents Of University Of California
23/01/2024 22:10
Oncternal Therapeutics Inc ONCT.O :
* ONCTERNAL THERAPEUTICS:ON JAN 22 ENTERED INTO AMENDMENT
NO. 4 TO
AMENDED & RESTATED LICENSE AGREEMENT BETWEEN CO,REGENTS OF
UNIVERSITY OF CALIFORNIA
Source text for Eikon: ID:
Further company coverage: ONCT.O
Recent news on Oncternal Therapeutics
See all newsOncternal Therapeutics Inc expected to post a loss of $3.19 a share - Earnings Preview
Brief: Oncternal Therapeutics Workforce Reduction Of About 10 Employees
U.S. STOCKS ON THE MOVE-Unity Software, Viking Holdings, Adobe
U.S. STOCKS ON THE MOVE-Gold miners, silver miners, Warner Bros Discovery
Oncternal hits record low on plans to scrap studies, explore strategic alternatives;